🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors market the drug there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Some experts said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach pharmaceutical, advertising, and customer regulations, risking fines, prosecution or prison.

Platform Reaction and Material Elimination

Based on the social media company, the platform has removed problematic material and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with numerous of users, filled with images of weight loss, positive reviews and detailed instructions for preparing or administering at home.

Within moments of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.

Product Information and Pricing

Inside these groups, posts display dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for the messaging service said it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering materials they can’t verify. Although the science behind retatrutide is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental product not yet approved … may subject users to possibly serious health risks”.